Duke’s prostate research program is further strengthened through the Duke Prostate Center (DPC), a multidisciplinary team of physicians, research scientists, and health care providers at Duke University Medical Center.
The DPC research staff is dedicated to understanding the underlying causes of prostate cancer and how it progresses. Specialists from urology, radiation oncology, pathology, and medical oncology use basic, translational, and clinical research to develop new treatments, including new surgical and radiation techniques, active surveillance, and novel drugs targeted at prostate cancer.
Click on a name below to learn about DPC faculty from other departments and divisions within Duke University Medical Center.
Medical Oncology
- Andrew J. Armstrong, MD, ScM, FACP
- Yuri A. Fesko, MD
- Daniel J. George, MD
- Michael R. Harrison, MD
Pathology
- Leslie G. Dodd, MD
- John F. Madden, MD
- Robin Vollmer, MD
Radiation Oncology
- Carol A. Hahn, MD
- Bridget F. Koontz, MD
- W. Robert Lee, MD, MS, Med
- Zelijko Vujaskovic, MD, PhD
Urology
- Michael N. Ferrandino, MD
- Stephen J. Freedland, MD
- Brant A. Inman, MD, FRCS©
- Judd W. Moul, MD, FACS
- Thomas J. Polascik, MD
- Cary N. Robertson, MD